Table 2.

The effect of EPA supplementation on anthropometric indices and serum HSP 27 levels

Variable		EPA (n = 18)	Placebo (n = 18)	P b
		mean ± SE	mean ± SE
Weight (kg)	Baseline	78.02 ± 2.98	78.30 ± 2.90	0.94
	End of trial	77.15 ± 2.98	78.23 ± 3.15	0.29d
	P c	0.08	0.89
	Change	-0.87 ± 0.48	-0.06 ± 0.49	0.45
BMI (kg/m2)	Baseline	28.48 ± 0.93	28.91 ± 1.27	0.77
	End of trial	28.16 ± 0.92	28.86 ± 1.32	0.25d
	P c	0.09	0.78
	Change	-0.32 ± 0.17	-0.04 ± 0.17	0.50
WC (cm)	Baseline	97.55 ± 2.27	97.47 ± 2.57	0.98
	End of trial	96.44 ± 2.39	97.08 ± 2.76	0.35d
	P c	0.02	0.55
	Change	-1.11 ± 0.44	-0.38 ± 0.63	0.18
HSP27 (ng/ml)	Baseline	39.77 ± 3.15	35.26 ± 2.23	0.24
	End of trial	33.28 ± 1.13	34.22 ± 1.67	0.03 d
	P c	0.008	0.45
	Change	-6.48 ± 2.16	-1.04 ± 1.34	0.03

EPA = Eicosapentaenoic Acid, SE = Standard Error, BMI = body mass index, WC = waist circumference, HSP 27 = Heat shock protein 27

^b Obtained from Independent sample t-test

^d Obtained from ANCOVA, adjusted for baseline values

^c Obtained from paired T test